Cheryl Cohen - 16 Jun 2022 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
Director
Signature
/s/ Sam Martin, attorney-in-fact for Cheryl L. Cohen
Issuer symbol
CLDX
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:05:44 UTC
Previous filing
15 Jun 2022
Next filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Non-Qualified Stock Option (right to buy) Award $0 +27,200 $0.000000 27,200 16 Jun 2022 Common Stock 27,200 $22.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 One third vests on the first, second and third anniversaries of the date of grant.